China's Fast Track Process For Medical Devices Growing With 46 Products Admitted So Far
This article was originally published in SRA
Executive Summary
The China Food and Drug Administration's fast track process for evaluating innovative medical devices is growing at a steady pace with 46 products admitted for evaluation so far, of which 17 were submitted in 2014 (of which six have been approved) and 29 in 2015 (of which two have been approved). The fast track route was launched on March 1, 20141.
You may also be interested in...
China's Medtech Regulatory Reforms Yet To Enter Steady Path
Medical device companies operating in China are still looking for clearer guidance that will help them make the most of the wide-ranging regulatory reforms introduced in the country since 2014.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.